Total submissions: 35
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000031539 | SCV000244456 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-08-10 | reviewed by expert panel | curation | IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000153 |
Invitae | RCV000044634 | SCV000072647 | benign | Hereditary breast ovarian cancer syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000031539 | SCV000154060 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-01-02 | criteria provided, single submitter | literature only | |
Gene |
RCV000168575 | SCV000167372 | benign | not specified | 2014-03-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000162664 | SCV000213106 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000768599 | SCV000219350 | likely benign | Breast and/or ovarian cancer | 2023-04-13 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000031539 | SCV000383714 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000044634 | SCV000494421 | benign | Hereditary breast ovarian cancer syndrome | 2015-04-09 | criteria provided, single submitter | clinical testing | Variant Summary: The variant of interst causes a missense change in a non-conserved position with 3/5 in silico programs predicting a "benign" outcome. The variant of interest has an observed allele frequency of 41/121940 (1/2976) including 1 homozygous occurrence. Functional analysis through the use of allelic imbalance implicated the variant does not affect splicing (Caux-Moncoutier_2009). The variant of interest has been reported in multiple affected individuals, however, it has shown lack of co-segregation within one family with an affected individual not carrying the variant of interest (Carvallone_2010). In addition, the variant of interest was reported to co-occur with another potentially pathogenic BRCA2 variant, c.759_759delinsACA and a potentially pathogenic BRCA1 variant, c.212+3A>G. Furthermore, multiple reputable databases/laboratories (ARUP, UMD, SCRP, GeneDx and Ambry Genetics) and publications (Lindor_2012, Easton_2007, and Cunningham_2014) classify the variant as "likely benign/benign/polymorphism." Therefore, taken all together, the variant of interest is classified as benign. |
Laboratory for Molecular Medicine, |
RCV000168575 | SCV000538487 | uncertain significance | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Clinvar: 7 labs classify as LB/Ben; ExAC: 0.1% (6/11554) Latino chromosomes |
Fulgent Genetics, |
RCV000031539 | SCV000575746 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-12-08 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Molecular Medicine, |
RCV000168575 | SCV000588100 | benign | not specified | 2017-04-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000168575 | SCV000602747 | benign | not specified | 2018-07-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162664 | SCV000683694 | likely benign | Hereditary cancer-predisposing syndrome | 2015-03-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000031539 | SCV000743306 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-07-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000031539 | SCV000744467 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000034445 | SCV000805720 | likely benign | not provided | 2017-01-10 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000031539 | SCV001139112 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001028067 | SCV001270127 | uncertain significance | Fanconi anemia complementation group D1 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Genetic Services Laboratory, |
RCV000168575 | SCV002070522 | likely benign | not specified | 2019-07-29 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV000044634 | SCV002504853 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Genetics Program, |
RCV000044634 | SCV002515118 | likely benign | Hereditary breast ovarian cancer syndrome | 2021-11-01 | criteria provided, single submitter | research | |
Sema4, |
RCV000162664 | SCV002536125 | benign | Hereditary cancer-predisposing syndrome | 2020-09-28 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000168575 | SCV002550347 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000044634 | SCV004014964 | benign | Hereditary breast ovarian cancer syndrome | 2023-04-11 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000031539 | SCV004016827 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034445 | SCV004132987 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | BRCA2: BP4, BS3:Supporting, BS1 |
Biesecker Lab/Clinical Genomics Section, |
RCV000034445 | SCV000043212 | probably not pathogenic | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Likely benign. |
Sharing Clinical Reports Project |
RCV000031539 | SCV000054144 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2006-03-16 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000031539 | SCV000146599 | not provided | Breast-ovarian cancer, familial, susceptibility to, 2 | no assertion provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV000168575 | SCV000591959 | benign | not specified | no assertion criteria provided | clinical testing | The BRCA2 p.Gly1771Asp variant was identified in 6 of 1934 proband chromosomes from individuals with breast cancer, ovarian cancer or prostate cancer and was not detected in 100 control chromosomes evaluated (Edwards 2003, Hadjisavvas 2003, Hondow 2011, Kauff 2002, Thirthagiri 2008, Toh 2008). The variant was listed in dbSNP (ID: rs80358755) “With probable-non-pathogenic allele” with a minor allele frequency of 0.0005 (1000 Genomes Project), and in the NHLBI Exome Sequencing Project (with a frequency of 0.0006 in European American alleles, increasing the likelihood that this may be a low frequency benign variant in certain populations of origin. The variant was also identified in HGMD, LOVD, the BIC database (43X with no clinical importance, 1X with unknown clinical importance), and in UMD (25X as a neutral variant). In UMD the variant was twice listed co-occur with a pathogenic variant in BRCA1 or BRCA2 (BRCA2 c.759 759delinsACA (p.Ser253ArgfsX24) and BRCA1 c.IVS5+3A>G (c.212+3A>G)), increasing the likelihood that this variant does not have clinical significance. Computational analyses (PolyPhen-2, SIFT, AlignGVGD) do not suggest a high likelihood of impact to the protein (though this information is not predictive enough to rule out pathogenicity), and two in silico studies using multifactorial likelihood-ratio models predict the variant to be neutral or of no clinical significance (Easton 2007, Lindor 2012). Furthermore, the p.Gly1771 residue is not conserved in mammals and lower organisms, and the variant amino acid aspartic acid (Asp) is present in rat and mouse, further increasing the likelihood that this variant is not clinically important. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as benign. | |
Diagnostic Laboratory, |
RCV000031539 | SCV000733266 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | no assertion criteria provided | clinical testing | ||
Biochemical Molecular Genetic Laboratory, |
RCV001028067 | SCV001190846 | benign | Fanconi anemia complementation group D1 | 2020-02-05 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000168575 | SCV001952004 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000168575 | SCV002034335 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000168575 | SCV002036522 | benign | not specified | no assertion criteria provided | clinical testing |